Listed

Larimar Therapeutics, Inc.

LRMRNasdaqCIK 1374690HealthcareFiscal year ends Dec 31

Reports and events: 239 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Larimar Therapeutics, Inc., Reports and events
FiledFormWhat it isAccession number
2019-08-0817:10 ET10-QQuarterly reportPeriod 2019-06-300001564590-19-030904
2019-08-0816:32 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-19-216900
2019-06-1317:15 ET8-K5.07 Shareholder vote results0001193125-19-172590
2019-05-3007:21 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-19-160233
2019-05-0917:01 ET10-QQuarterly reportPeriod 2019-03-310001564590-19-018086
2019-05-0916:26 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-19-143016
2019-04-2617:19 ETDEF 14AProxy statementPeriod 2019-06-130001193125-19-122675
2019-04-0416:47 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-097949
2019-03-1417:25 ET10-KAnnual reportPeriod 2018-12-310001564590-19-007863
2019-03-1116:12 ET8-K2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-19-070841
2019-02-1517:00 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation0001193125-19-042548
2019-01-1707:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-19-010961
2018-11-2607:17 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-333393
2018-11-0917:10 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-18-323890
2018-11-0916:31 ET10-QQuarterly reportPeriod 2018-09-300001564590-18-028944
2018-11-0716:15 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-320926
2018-08-0916:32 ET10-QQuarterly reportPeriod 2018-06-300001193125-18-244422
2018-08-0716:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-241169
2018-08-0216:24 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-236631
2018-06-2817:01 ET8-K1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-207787
2018-06-2507:15 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-18-201664
2018-06-0717:06 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-18-186943
2018-05-3017:17 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-18-178715
2018-05-1016:34 ET10-QQuarterly reportPeriod 2018-03-310001193125-18-159281
2018-05-0816:09 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-155978
2018-04-1817:23 ETDEF 14AProxy statementPeriod 2018-06-060001193125-18-121231
2018-03-0916:44 ET10-KAnnual reportPeriod 2017-12-310001193125-18-077456
2018-03-0616:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-18-072113
2018-01-0516:46 ET8-K1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-18-004559
2017-11-0717:14 ET10-QQuarterly reportPeriod 2017-09-300001193125-17-335910
2017-11-0716:58 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-335861
2017-10-1217:09 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-17-308904
2017-08-0916:28 ET10-QQuarterly reportPeriod 2017-06-300001193125-17-252840
2017-08-0816:21 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-251371
2017-06-2316:07 ET8-K5.07 Shareholder vote results0001193125-17-211752
2017-05-0916:30 ET10-QQuarterly reportPeriod 2017-03-310001193125-17-164257
2017-05-0916:23 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-164232
2017-05-0416:12 ET8-K2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-17-158697
2017-04-2816:27 ETDEF 14AProxy statementPeriod 2017-06-210001193125-17-148291
2017-03-1016:07 ET10-KAnnual reportPeriod 2016-12-310001193125-17-078784
2017-03-0916:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-076883
2016-11-0916:32 ET10-QQuarterly reportPeriod 2016-09-300001193125-16-764420
2016-11-0916:11 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-764348
2016-08-0518:07 ET10-QQuarterly reportPeriod 2016-06-300001193125-16-672131
2016-08-0416:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-671803
2016-07-1917:20 ET8-K5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-651297
2016-07-0116:30 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results0001193125-16-640536
2016-05-1016:53 ET10-QQuarterly reportPeriod 2016-03-310001193125-16-585718
2016-05-1016:12 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-16-585593
2016-05-0417:23 ETDEF 14AProxy statementPeriod 2016-06-300001193125-16-577958

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 17:49 ET. Listed shows no prices and gives no investment advice.